Cargando…
Identidication of novel biomarkers in non-small cell lung cancer using machine learning
Lung cancer is one of the leading causes of cancer-related deaths worldwide, and non-small cell lung cancer (NSCLC) accounts for a large proportion of lung cancer cases, with few diagnostic and therapeutic targets currently available for NSCLC. This study aimed to identify specific biomarkers for NS...
Autores principales: | Wang, Fangwei, Su, Qisheng, Li, Chaoqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537298/ https://www.ncbi.nlm.nih.gov/pubmed/36202977 http://dx.doi.org/10.1038/s41598-022-21050-5 |
Ejemplares similares
-
Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma
por: Wang, Fangwei, et al.
Publicado: (2022) -
The Machine Learning Model for Distinguishing Pathological Subtypes of Non-Small Cell Lung Cancer
por: Zhao, Hongyue, et al.
Publicado: (2022) -
Integration of metabolomics and machine learning revealed tryptophan metabolites are sensitive biomarkers of pemetrexed efficacy in non‐small cell lung cancer
por: Sun, Runbin, et al.
Publicado: (2023) -
Machine learning in non-small cell lung cancer radiotherapy: A bibliometric analysis
por: Zhang, Jiaming, et al.
Publicado: (2023) -
Prediction of bone metastasis in non-small cell lung cancer based on machine learning
por: Li, Meng-Pan, et al.
Publicado: (2023)